Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUtil Regulatory News (UTL)

Share Price Information for Util (UTL)

Share Price is delayed by 15 minutes
Get Live Data
199.00    1.00 (0.51%)
Bid:
194.00
Ask:
204.00
Spread: 10.00 (5.155%)
Market Cap: £179.97m
UTL Live PriceLast checked at - London Stock Exchange

Intraday Util Share Chart

Portfolio update – Diraq

22 May 2026 11:02

RNS Number : 4826F
UIL Limited
22 May 2026
 

22 May 2026

UIL LIMITED

(LEI Number: 213800CTZ7TEIE7YM468)

Portfolio update - Diraq

The Board of UIL Limited ("UIL" or the "Company") is pleased to announce that its investee company Diraq Pty Ltd ("Diraq") has signed a Letter of Intent (LOI) with the U.S. Department of Commerce for up to $38 million in proposed federal funding from the CHIPS Research and Development Office. This award will support production and scaling of fault-tolerant silicon quantum computing processors via the U.S. semiconductor industry.

Diraq is pioneering the use of silicon-based quantum processors, which have the ability to contain millions of qubits on a single chip, and are fabricated with existing semiconductor manufacturing processes. This investment will accelerate Diraq's roadmap to enable an end-to-end quantum supply chain. Founded in Sydney, Australia, Diraq has U.S. offices and labs in Palo Alto and Chicago, and will soon open a significant new operation in Los Angeles. The company is growing its team and business in the United States and is actively working with domestic partners to further accelerate the U.S. quantum ecosystem

UIL's investment in Diraq is through Allectus Quantum Holdings Limited, an investment holding company for quantum technology investments with its current portfolio comprising only an investment in Diraq. As at 30 April 2026, Allectus Quantum Holdings Limited represented 8.4% of UIL's investment portfolio.

 

 

Name of contact and telephone number for enquiries:

 

Charles Jillings

ICM Investment Management Limited

Telephone: 01372 271486

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUKLLBLQELEBBK
Date   Source Headline
10th Jul 202611:23 amRNSNet Asset Value(s)
10th Jul 20269:36 amRNSPublication of monthly factsheet
9th Jul 20264:57 pmRNSPurchase of 2026 ZDP Shares
9th Jul 202611:50 amRNSNet Asset Value(s)
8th Jul 202611:15 amRNSNet Asset Value(s)
7th Jul 202612:08 pmRNSNet Asset Value(s)
6th Jul 20261:18 pmRNSSale of 2028 ZDP Shares
6th Jul 202611:22 amRNSNet Asset Value(s)
3rd Jul 20265:24 pmRNSPurchase of 2026 ZDP Shares
3rd Jul 202611:43 amRNSNet Asset Value(s)
2nd Jul 202612:02 pmRNSNet Asset Value(s)
1st Jul 202612:37 pmRNSNet Asset Value(s)
1st Jul 202612:16 pmRNSDirector/PDMR Shareholding - Shillson
1st Jul 202612:15 pmRNSDirector/PDMR Shareholding - Durhager
1st Jul 202612:15 pmRNSDirector/PDMR Shareholding - Bridges
30th Jun 20261:58 pmRNSNet Asset Value(s)
29th Jun 20263:01 pmRNSNet Asset Value(s)
26th Jun 20265:25 pmRNSSale of 2028 ZDP Shares
26th Jun 20265:22 pmRNSPurchase of 2026 ZDP Shares
26th Jun 202611:58 amRNSNet Asset Value(s)
25th Jun 20264:59 pmRNSSale of 2028 ZDP Shares
25th Jun 202611:22 amRNSNet Asset Value(s)
24th Jun 20264:59 pmRNSPurchase of 2026 ZDP Shares
24th Jun 202612:12 pmRNSNet Asset Value(s)
23rd Jun 20265:33 pmRNSPurchase of 2026 ZDP Shares
23rd Jun 202612:17 pmRNSNet Asset Value(s)
22nd Jun 202611:56 amRNSNet Asset Value(s)
19th Jun 202611:59 amRNSPublication of monthly factsheet
19th Jun 202611:42 amRNSNet Asset Value(s)
18th Jun 202612:53 pmRNSNet Asset Value(s)
17th Jun 202612:46 pmRNSNew loan facility
17th Jun 202612:28 pmRNSNet Asset Value(s)
16th Jun 202612:03 pmRNSNet Asset Value(s)
15th Jun 202612:00 pmRNSNet Asset Value(s)
12th Jun 202611:40 amRNSNet Asset Value(s)
11th Jun 202611:52 amRNSNet Asset Value(s)
10th Jun 202611:42 amRNSNet Asset Value(s)
9th Jun 202612:54 pmRNSDirector/PDMR Shareholding - Durhager
9th Jun 202612:02 pmRNSNet Asset Value(s)
8th Jun 202611:44 amRNSNet Asset Value(s)
5th Jun 20265:52 pmRNSDirector/PDMR Shareholding - Durhager
5th Jun 202612:05 pmRNSNet Asset Value(s)
4th Jun 202611:47 amRNSNet Asset Value(s)
3rd Jun 202612:37 pmRNSNet Asset Value(s)
2nd Jun 20265:34 pmRNSDirector/PDMR Shareholding - Durhager
2nd Jun 202612:33 pmRNSDividend Declaration - Q3 2025-26
2nd Jun 202611:51 amRNSNet Asset Value(s)
1st Jun 202612:41 pmRNSNet Asset Value(s)
29th May 202611:46 amRNSNet Asset Value(s)
28th May 202611:54 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.